Font Size: a A A
Keyword [mesothelioma]
Result: 41 - 60 | Page: 3 of 4
41. Curcumin Inhibits Proliferation And Induces Apoptosis In Malignant Pleural Mesothelioma RN5 Cells
42. Combination Of CT And SMRP In Diagnosis Of Early Malignant Pleural Mesothelioma In Rats
43. Prophylactic Radiotherapy For Procedure Tract Metastases In Malignant Pleural Mesothelioma:A Meta-analysis
44. Effects Of RNA Interference On The Biological Behavior Of Fibulin-3 Gene Silencing On The Biological Behavior Of Malignant Pleural Mesothelioma
45. The Value Of Immunocytochemistry And Fluorescence In Situ Hybridization In The Diagnosis Of Serous Effusion Malignant Mesothelioma
46. Clinical Analysis Of 30 Cases With Malignant Pleural Mesothelioma And Literature Review
47. SETDB1 Tumor Suppressor In Malignant Mesothelioma
48. Clinical Characteristics And Prognosis Analysis Of 60 Cases Of Malignant Pleural Mesothelioma
49. Mechanism Analysis Of EZH2 Regulating Hedgehog-Gli Signaling Pathway In Malignant Pleural Mesothelioma
50. Predictors Of Survival In Malignant Pleural Mesothelioma Patients Undergoing Thoracoscopy And Tumor Markers
51. Expression And Clinicopathological Significance Of BAP1,NF2,p16 And CUL1 In Malignant Mesothelioma
52. Effect Of MiR-182 On Malignant Pleural Mesothelioma Cells
53. Mechanism Of Hedgehog Signaling Pathway In Proliferation Of Malignant Pleural Mesothelioma Cells
54. Association of patient-reported outcomes with progression-free survival in malignant pleural mesothelioma
55. Delivery of paclitaxel via pH-responsive polymeric nanoparticles for prevention of lung cancer and mesothelioma recurrence
56. The role of cap-dependent translation in malignant pleural mesothelioma and non-small cell lung cancer
57. The role of host stromal cells in a transplanted orthotopic murine model of diffuse malignant mesothelioma
58. Intraperitoneal Chemotherapy for the Treatment of Malignant Peritoneal Mesothelioma
59. Environmental asbestos and incident mesothelioma California, 1988--1997
60. CSPG4 as a potential target of antibody-based immunotherapy for Malignant Mesothelioma
  <<First  <Prev  Next>  Last>>  Jump to